Pharma Focus Asia

Syneos Health Collaborates with Microsoft

Tuesday, March 21, 2023

Syneos Health® announced a strategic multi-year agreement with Microsoft. The multi-year agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Through this collaboration, Syneos Health will deliver technology and data solutions with Microsoft that accelerate clinical development and elevate commercial performance for biopharma customers.

Based on AI-enabled platform, Syneos Health will be able to process and analyse data to fast-track timelines, optimise resource allocation and unlock clinical trial efficiencies. These capabilities will allow for superior site selection and reduced enrolment timelines to bring new treatments to patients faster. Syneos Health combines AI expertise with solutions that help make a big difference in patients' lives.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024